BACKGROUND: Spontaneous firing of sinoatrial node cells (SANCs) is regulated by cAMP-mediated, PKA (protein kinase A)-dependent (cAMP/PKA) local subsarcolemmal Ca 2+ releases (LCRs) from RyRs (ryanodine receptors). LCRs occur during diastolic depolarization and activate an inward Na + /Ca 2+ exchange current that accelerates diastolic depolarization rate prompting the next action potential. PDEs (phosphodiesterases) regulate cAMP-mediated signaling; PDE3/PDE4 represent major PDE activities in SANC, but how they modulate LCRs and basal spontaneous SANC firing remains unknown.
N
ormal automaticity of the heart is initiated within cardiac pacemaker, the sinoatrial node; excitation then propagates to atria and ventricles to trigger cardiac muscle contraction, which delivers blood to the body. Spontaneous beating of the sinoatrial node is emanated from beating of sinoatrial node pacemaker cells (SANCs), which spontaneously generate action potentials (APs) because of gradual depolarization of the membrane potential during diastole, that is, diastolic depolarization (DD). 1 Spontaneous firing of SANC is critically dependent on surface membrane ion channels and SR (sarcoplasmic reticulum) generated local subsarcolemmal Ca 2+ releases (LCRs). Rhythmic LCRs appear during late DD and activate an inward Na + /Ca 2+ exchange current (I NCX ), which accelerates DD rate and prompts the generation of subsequent AP. 2 The ionic currents in SANC include hyperpolarization activated funny current I f , L-type and T-type Ca 2+ currents (I Ca,L , I Ca,T ), delayed rectifier potassium current (I K ), Na + /Ca 2+ exchange current (I NCX ), etc. Both ionic channels and intracellular SR Ca 2+ cycling in SANC work together to guarantee stability and flexibility of cardiac pacemaker function. 3 cAMP is a ubiquitous second messenger that modulates substantial number of cell processes, for example, cAMP-mediated activation of PKA (protein kinase A)-dependent phosphorylation of multiple proteins. Constitutive activation of adenylyl cyclases in rabbit SANC generates high basal level of both cAMP and cAMP-mediated PKA-dependent phosphorylation, which are required for the generation of spontaneous LCRs and normal spontaneous beating of SANC. 4, 5 Although high basal cAMP production in SANC might indicate low cAMP degradation by PDEs (phosphodiesterases), an increase in cAMP level and spontaneous SANC beating rate after suppression of basal PDE activation by broad-spectrum PDE inhibitor IBMX (1-methyl-3-isobutylxanthine) exceeds that in response to the stimulation of β-AR (β-adrenergic receptors) with isoproterenol. This indicates the presence of high basal PDE activity in SANC. 5 More than 60 PDE isoforms, which comprise 11 families (PDE1-11), exist in mammalian cells, and at least 4 families PDE1 to PDE4 can hydrolyze cAMP in the heart. PDE1 is activated by Ca 2+ /calmodulin, PDE2 is stimulated by cGMP, PDE3 is inhibited by cGMP, and PDE4 is specific for cAMP. Although PDE3 can hydrolyze both cAMP and cGMP, the catalytic rates for cAMP are 5-to 10-fold higher, than for cGMP, which makes PDE3 highly specific for cAMP. 6 Inhibition of PDE3 causes sinoatrial tachycardia in guinea pigs, 7 rabbits, 5, 8 dogs, 9 and humans. 10 PDE4 is the dominant PDE isoform in the murine heart, 6 and inhibition of either PDE3 or PDE4 produces sinoatrial tachycardia in mice 11 and rats. 8 Several ionic currents involved in the generation of the DD are regulated by PDEs, that is, inhibition of PDE3 in rabbit SANC increases I Ca,L , I K and shifts voltage dependence of I f activation to more positive potentials. 5, 12, 13 Funny current I f is directly activated by cAMP mostly through HCN4 (hyperpolarization-activated cyclic nucleotide-gated 4) channel.
14 LCRs are also regulated by PDEs, that is, PDE inhibition reduces the LCR period, shifting LCR occurrence to earlier times during DD, and increases LCR number and size as RyR (ryanodine receptor) activation becomes more synchronized via RyR recruitment. The earlier and stronger LCR-generated Ca 2+ release results in an increase and earlier activation of I NCX , acceleration of the DD rate, and increase in the spontaneous SANC beating rate. 5 There is a growing evidence to suggest that whereas individual PDE3 or PDE4 inhibition have minor or no effect on their own, combined PDE3+PDE4 inhibition could produce a large synergistic response, creating effect which is greater than the simple sum of separate PDE3 and PDE4 inhibition. 15, 16 Synergistic effects of concurrent PDE3+PDE4 inhibition have been previously observed in variety of cell types, including glucose uptake by brown adipose tissue, 16 regulation of smooth muscle cell motility, 17 and increase in contractility by rat ventricular myocyte (VM) 18 or right atrium.
19
PDE3 and PDE4 represent major PDE activities in the rabbit sinoatrial node, that is, their combined activity in cytosolic or SR fraction accounts for ≈50% and ≈90% of total cAMP-PDE activity, respectively, whereas contribution from other PDE subtypes is relatively small. 20 However, how PDE3 and PDE4 regulate spontaneous beating rate of cardiac pacemaker cells and whether there is synergistic effect of concurrent PDE3 and PDE4 activation
WHAT IS KNOWN?
• Basal spontaneous beating of rabbit sinoatrial node cells is regulated by ionic currents and local subsarcolemmal Ca 2+ releases from RyRs (ryanodine receptors).
• Sinoatrial node cells have elevated basal level of cAMP and cAMP-mediated PKA (protein kinase A)-dependent phosphorylation, regulated by PDE (phosphodiesterase)3 and PDE4 activation.
WHAT THE STUDY ADDS?
• PDE3A, PDE4B, and PDE4D are the major PDE subtypes expressed in rabbit sinoatrial node cell; PDE3A colocalizes with α-actinin, PDE4D, SERCA (sarcoplasmic reticulum Ca 2+ ATP-ase), and phospholamban in Z-lines, whereas PDE3A and PDE4B colocalize beneath sarcolemma.
• Basal cardiac pacemaker function is regulated by dual PDE3+PDE4 activation, which operates in a synergistic manner to limit cAMP-mediated PKAdependent phosphorylation and to suppress local subsarcolemmal Ca 2+ releases, decreasing the spontaneous sinoatrial node cell beating rate.
remains unknown. The aims of the present study were to determine (1) the major PDE (ie, PDE3 and PDE4) subtypes expressed in rabbit SANC; (2) how major PDE3 and PDE4 subtypes are distributed within SANC; (3) whether PDE3 and PDE4 work in a synergistic manner to regulate spontaneous SANC firing; and, if so, (4) what specific targets are modulated by concurrent PDE3+PDE4 activation. 
MATERIALS AND METHODS

An
SANC Preparations and Electrophysiological Recordings
SANCs or VMs were isolated from rabbit hearts, as previously described 5 ; only regular spontaneously beating SANCs were selected for experiments. SANCs were continuously superfused with the Tyrode solution, which was switched to the Tyrode solution containing chemicals used in the experiment. The bath temperature was maintained at 35±0.5°C. The perforated patch-clamp technique and whole cell patch-clamp technique were used to record APs and I Ca,L , respectively. Spontaneous beating of SANC was recorded for at least 10 to 15 minutes in the basal state, followed by drug application. Effects of PDE inhibitors on the beating rate were also studied in the presence of 3 μmol/L ryanodine or I f current inhibitors 5 μmol/L ivabradine or 2 mmol/L Cs + .
Confocal Ca 2+ Transients and LCRs
To measure cytosolic Ca 2+ , SANCs were loaded with fluo-3 AM (Molecular Probes, Eugene, OR); images were recorded using confocal microscopy in the line-scan mode, as previously described. 21 
Cell Permeabilization
A subset of SANCs were permeabilized with 0.01% saponin, and LCR number was normalized per 100 μm of the linescan image and 1 s time interval, as previously described.
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RNA Extraction and Reverse Transcription-Quantitative Polymerase Chain Reaction
RNA was extracted from isolated rabbit SANC (n=4-9 pooled samples, each sample collected from 3 rabbits) or left VM (n=6 rabbits) with RNeasy Mini Kit (Qiagen, Valencia, CA) and DNAse on column digestion. For complementary DNA preparation, we used MMLV (Moloney murine leukemia virus) reverse transcriptase (Promega, WI). VM and pooled SANC samples were tested via reverse transcription-quantitative polymerase chain reaction, using ABI Prism 7900HT Sequence Detection System (Applied Biosystems).
Western Blotting
To detect different PDE subtypes, sinoatrial node and left ventricular tissues were frozen in liquid nitrogen, powdered, and resuspended in RIPA (radioimmunoprecipitation assay) lysis buffer. PDE3A, PDE4A, PDE4B, and PDE4D in the sinoatrial node and LV were detected using PDE3A, PDE4A, and PDE4D antibody (Abcam, Cambridge, MA) and custom-made PDE4B antibody (GenScript, Piscataway, NJ). The detection of PLB (phospholamban) phosphorylation at the PKA-dependent site was performed in isolated SANC, using a phosphorylation-specific P-Ser 16 PLB antibody (Badrilla, United Kingdom) as previously described. 
Statistical Analysis
Data were presented as mean±SEM. The statistical significance of effects was evaluated with PRISM software, that is, Student t test, column statistics, or ANOVA where appropriate. A value of P <0.05 was considered statistically significant.
RESULTS
RNA Abundance, Protein Expression, and Distribution of Different PDE Subtypes in Rabbit SANC
Total RNA from SANC and VM was reverse transcribed to generate complementary DNA, and relative abundance of complementary DNA from different PDE transcripts was measured with reverse transcriptionquantitative polymerase chain reaction. Although PDE1A RNA was more abundant in SANC than in VM, 23 PDE3A, PDE4B, and PDE4D were the major PDE subtypes expressed in both rabbit SANC and VM (Figure 1A) . There was comparable expression of PDE3A and PDE4B in rabbit SANC which surpassed expression of other PDE subtypes ( Figure 1A ). Consistent with the reverse transcription-quantitative polymerase chain reaction data, Western blots demonstrated more abundant PDE3A and PDE4A protein expression in the rabbit left ventricle, compared with the sinoatrial node ( Figure 1B and 1C) . Expression of PDE4B protein was similar in both tissues ( Figure 1D ), whereas expression of PDE4D protein was more abundant in the rabbit sinoatrial node ( Figure 1E ).
The intracellular distributions of the most abundant isoforms of PDE3 (PDE3A) and PDE4 (PDE4B and PDE4D) in rabbit SANC were further examined using immunostaining. Figure 2 shows that PDE3A was detected both beneath sarcolemma and in a striated pattern within Z-lines of rabbit SANC, colocalized with the Z-lineassociated protein α-actinin ( Figure 2A ). Intensity plots in the Figure 2A , right, demonstrated codistribution of PDE3A and α-actinin with an interval of 1.80±0.01 μm (n=13 SANC). Costaining of PDE3A with anti-PDE4B antibody showed higher labeling intensity in the overlay images beneath sarcolemma of SANC ( Figure 2B ), whereas PDE4D colocalized with PDE3A in striated patterns inside SANC ( Figure 2C ). Because PDE3A in human myocardium colocalizes with SERCA and PLB, 24 we studied whether the similar colocalization of PDE3A existed in rabbit SANC. Costaining of PDE3A with SER-CA or PLB antibodies showed that, indeed, PDE3A colocalized with SERCA and PLB in SANC ( Figure 2D and 2E). Considering that PDE4D colocalized with PDE3A ( Figure 2C ), which colocalized with SERCA and PLB, PDE4D should be also in the proximity of major SR proteins.
Basal Spontaneous Firing of Rabbit SANC Is Regulated by Dual (PDE3+PDE4) Activation
Though our previous report identified PDE3 as a major PDE subtype regulating basal spontaneous beating of SANC, 5 the relatively high concentration (50 μmol/L) of milrinone used could suppress not only PDE3 activity but also that of PDE4. 20, 25 To clarify whether the activation of PDE3 alone or combined PDE3+PDE4 activation regulated basal spontaneous SANC firing, we used milrinone concentration of 10 μmol/L, considered to be specific for PDE3. Milrinone at that concentration increased spontaneous SANC firing by only ≈20% (data not shown), similar to selective PDE3 inhibitor cilostamide (0.3 μmol/L), 20, 26 which increased DD rate and the spontaneous SANC beating rate by ≈30% (P<0.05) and ≈20% (P<0.05), respectively ( Figure 3 ). An acceleration of spontaneous SANC firing by selective PDE4 inhibitor rolipram (2 μmol/L) 27, 28 did not reach statistical significance (Figure 3) . To verify the efficacy of PDE4 inhibition by rolipram, its concentration was further increased to 20 and 100 μmol/L, but no further increase in the spontaneous SANC beating rate was observed (data not shown). Concurrent dual inhibition of PDE3+PDE4 by a combination of cilostamide and rolipram, however, markedly increased DD rate and spontaneous SANC beating rate by ≈70% (P<0.05) and ≈48% (P<0.01), respectively, an effect matching that of broad-spectrum PDE inhibitor IBMX (Figure 3) . An acceleration of spontaneous SANC firing by concurrent dual PDE3+PDE4 inhibition by ≈2-fold exceeded the sum of increases in spontaneous firing produced by inhibition of PDE3 (≈20%) and PDE4 (≈5%) alone, indicating that dual PDE3+PDE4 activation regulated basal firing of cardiac pacemaker cells in a synergistic manner.
Basal PDE3+PDE4 Activation Suppressed Local Ca 2+ Releases in Intact SANC
During spontaneous beating, AP-induced Ca 2+ transient partially depletes SR and abolishes LCRs when SR Ca 2+ content is replenished by SERCA spontaneous LCRs begin to occur. 21 The LCR period is a time interval between prior AP-induced global Ca 2+ transient and the LCR occurrence, and it defines the time of I NCX activation and thus generation of the next AP. Considering the essential role of LCRs for the regulation of basal spontaneous SANC firing, we examined how inhibition of PDE3 or PDE4 alone or dual PDE3+PDE4 inhibition affected the LCR period and characteristics. Cilostamide markedly increased the LCR size and number per each spontaneous cycle by ≈20% each (P<0.05) and decreased the LCR period by ≈15% (P<0.05; ( Figure I in the Data Supplement), although changes in these parameters by rolipram were minor (Figure II in the Data Supplement). Concurrent inhibition of PDE3+PDE4, however, increased both the LCR size and number per each spontaneous cycle by ≈45% (P<0.01) each and decreased the LCR period by ≈40% (P<0.01) that was highly correlated with concomitant decrease in the spontaneous cycle length (Figure 4) . Therefore, basal LCRs could be a primary target of dual PDE3+PDE4 regulation. To verify role of LCRs for PDE3+PDE4-dependent regulation of spontaneous SANC firing, we used ryanodine, which locks RyRs in a subconductance open state, depleting the SR Ca 2+ content and eventually eliminating LCRs. When RyR Ca 2+ release was inhibited by ryanodine, combined PDE3+PDE4 inhibition produced only a minor increase in the spontaneous SANC beating rate ( Figure 5C ), indicating a critical role of LCRs in dual (PDE3+PDE4)-dependent regulation of cardiac pacemaker function.
A hyperpolarization activated funny current I f regulates early part of DD and is directly activated by intracel- 14 To assess functional importance of I f current for PDE-dependent regulation of spontaneous SANC firing, we compared effects of dual PDE3+PDE4 inhibition in the presence and absence of funny current inhibitors ivabradine 29 ( Figure Figure 5D ). This indicated that I f current was not a target of dual PDE3+PDE4 activation.
Concerted PDE3+PDE4 Activation
Regulated Basal L-Type Ca 2+ Current Amplitude L-type Ca 2+ current generates an AP upstroke in primary pacemaker cells and provides Ca 2+ available for pumping into SR, and I Ca,L is regulated by PDEs both in VM 31 and SANC 5 and could be another target of concurrent PDE3+PDE4 activation. PDE4 inhibitor rolipram did not change I Ca,L amplitude in isolated rabbit SANC, whereas PDE3 inhibitor cilostamide markedly increased I Ca,L by ≈60% (P<0.01; Figure 6 ). Dual PDE3+PDE4 inhibition, however, increased I Ca,L by ≈100% (P<0.01), an effect comparable to that of IBMX, which markedly exceeded combined effects of separate PDE3 and PDE4 inhibition ( Figure 6 ). Thus, dual PDE3+PDE4 activation regulated basal I Ca,L amplitude in SANC in a synergistic manner, reducing basal Ca 2+ influx through L-type Ca 2+ channels and limiting amount of Ca 2+ available for pumping into SR.
Concurrent PDE3+PDE4 Activation Regulated Intrinsic SR Ca 2+ Cycling in Permeabilized SANC
To study whether dual PDE3+PDE4 activation regulated intrinsic SR Ca 2+ cycling, avoiding presence of functional ionic channels, we used saponin-permeabilized SANC. Like in intact SANC, no changes in LCR parameters were recorded during inhibition of PDE4 alone in permeabilized SANC ( Figure VC and VD in the Data Supplement), whereas inhibition of PDE3 alone increased the LCR size by ≈10% (P<0.05), but changes in LCR number did not reach statistical significance ( Figure VA and VB in the Data Supplement). Dual PDE3+PDE4 inhibition, however, substantially augmented both LCR number by ≈60% (P<0.01) and LCR size by ≈25% (P<0.01; Figure 7A and 7B), exceeding additive effects produced by inhibition of PDE3 or PDE4 alone. Thus, dual PDE3+PDE4 activation regulated the intrinsic SR Ca 2+ cycling in a synergistic manner, which could be due, in part at least, to an increase in the SR Ca 2+ load. 32 To test this idea, we applied a pulse of caffeine, which rapidly empties the SR Ca 2+ store, directly on SANC. Dual PDE3+PDE4 inhibition markedly (P<0.05) increased the SR Ca 2+ content ( Figure 7C and 7D) , confirming that augmentation of LCR parameters was partially because of an increase in the SR Ca 2+ load.
Combined PDE3+PDE4 Activation Regulated the LCR Period and Spontaneous SANC Cycle Length Through Modulation of the SR Ca
2+
Refilling Kinetics
The increase in the SR Ca 2+ load in response to dual PDE3+PDE4 inhibition in permeabilized SANC (without augmented Ca 2+ supply via I Ca,L ) could be attributable, at least in part, to an increase in SERCA activity, which is regulated by cAMP-mediated PKA-dependent phosphorylation of PLB at Ser 16 site. 33 Inhibition of PDE3 or PDE4 alone in rabbit SANC increased PLB phosphorylation by ≈21% (P>0.05) and ≈17% (P>0.05), respectively ( Figure 8A ). Concurrent PDE3+PDE4 inhibition, however, increased PLB phosphorylation by ≈108% (P<0.05), an effect that surpassed by ≈2-fold the additive effects of separate PDE3 or PDE4 inhibition and was comparable to that of IBMX ( Figure 8A ). Enhanced PLB phosphorylation by dual PDE3+PDE4 inhibition would increase SERCA efficiency and shorten the SR Ca 2+ refilling time reflected in the decrease of the decay of AP-induced Ca 2+ transient at 90% (T-90). 34 Indeed, there was a close link between gradations in the increase of PLB phosphorylation during separate or concurrent PDE3 and PDE4 inhibition and reduction in the SR refilling times (indexed by T-90; Figure 8B ). Reductions in T-90 during inhibition of PDE3 or PDE4 alone, concurrent PDE3+PDE4 inhibition, or IBMX were replicated in reductions of LCR periods, that were closely correlated to decreases in spontaneous SANC cycle lengths (Figure 8 ).
DISCUSSION
Here, we established the following order of messenger RNA expression of major cAMP-degrading PDE (PDE1-4) in rabbit SANC, that is, PDE3 and PDE4 were the dominant PDEs, with PDE3A and PDE4B as the most abundant isoforms, whereas expression of other PDE subtypes was significantly less ( Figure 1A) . Consistent with RNA data, expression of PDE3A and PDE4A protein in the rabbit left ventricle exceeded that in the sinoatrial node. Expression of PDE4B or PDE4D protein, however, was either comparable or markedly higher in the sinoatrial node, indicating that these PDEs were the most abundant PDE4 isoforms in the rabbit sinoatrial node ( Figure 1B through 1E) .
PDEs represent a unique mechanism of cAMP degradation, and targeting PDEs to specific intracellular loca- tions might create local pools microdomains with high or low cAMP levels, in latter case PDEs act like black holes converting cAMP into 5′-AMP and thus protecting specific compartments from cAMP influx and PKA activation. 35 In rabbit sinoatrial node, PDE3 is the dominant cAMP hydrolyzing activity representing ≈75% of total PDE activity in the SR-enriched fraction and ≈30% in the cytosolic fraction. 20 Compared with PDE3, PDE4 activity is less, and its major part is in cytosolic fraction ≈20% and only ≈10% in the SR-enriched fraction. 20 In the human ventricle, both PDE3A and PDE4D associate with SR (ie, SERCA) and play a primary role in regulation of cardiac contractility. 24, 36 PDE4D is also a dominant PDE4 subtype in the human atrium, and PDE4 inhibition increases frequency of Ca 2+ sparks and initiates Ca 2+ waves in human atrial myocytes (AMs). 37 Both PDE3A and PDE4D are colocalized with SERCA-PLB complex in the mouse heart. 26, 36 An increase in cardiac contractility, associated with improved SERCA function and linked to augmented PLB phosphorylation, was reported in both PDE3A and PDE4D knockout mice. 26, 36 Besides, PDE3A knockout mice have an increased basal heart rate. 26 Our study provides the first immunocytochemical evidence for the organization of major PDE3 and PDE4 subtypes in SANC. Both PDE3A and PDE4D were distributed in a striated pattern colocalized with the Z-line protein α-actinin, which did not rely on the presence of transverse tubules because they are absent in SANC. Similar to human or mouse VMs, PDE3A and PDE4D in rabbit SANC were colocalized with SR proteins SERCA and PLB (Figure 2 ), suggesting that these PDE isoforms could likely regulate cAMP-mediated PKA-dependent phosphorylation of PLB in SANC. Unphosphorylated PLB inherently inhibits SERCA, but when PLB is phosphorylated by PKA it dissociates from SERCA and relieves its inhibition, promoting Ca 2+ reuptake and speed at which SR is refilled with Ca 2+ . 33 Compared with VM, rabbit SANCs have increased amount of SERCA and reduced amount of PLB, suggesting more efficient SERCA function in the basal state. 22 Our results demonstrated that dual PDE3+PDE4 activation in rabbit SANC regulated basal SERCA function in a synergistic manner through the modulation of PLB phosphorylation ( Figure 8A ). Indeed, graded increases in PLB phosphorylation during separate or concurrent PDE3 and PDE4 inhibition were closely correlated with reductions in SR Ca 2+ refilling times (T-90) and concurrent decreases in LCR periods and spontaneous SANC cycle lengths (Figure 8 ). Dual PDE3+PDE4 inhibition markedly augmented LCR number and size (Figure 4 ) due, at least in part, to an elevation of the SR Ca 2+ content ( Figure 7 ) and consequent synchronization of RyR Ca 2+ release. The augmented RyR Ca 2+ release beneath sarcolemma triggered elevated inward I NCX at earlier times hastening DD rate, speeding up the occurrence of the next AP and thus increasing the spontaneous SANC beating rate ( Figures 3, 4, and 8 ). When RyRs were functionally disabled by ryanodine, dual PDE3+PDE4 inhibition produced only minor increase in the spontaneous SANC beating rate ( Figure 5 ), confirming critical role of LCRs for PDE3+PDE4-dependent regulation of spontaneous SANC firing. Thus, concurrent PDE3+PDE4 activation operated in a synergistic manner to restrict basal spontaneous SANC beating rate through delay of LCR occurrence and suppression of LCR parameters.
L-type Ca 2+ channels are a well-known target of cAMP-mediated PKA-dependent pathway regulated by PDE activation. Selective PDE3 inhibition markedly increased I Ca,L amplitude both in human and rabbit AM, whereas PDE4 inhibition was without effect; dual PDE3+PDE4 inhibition, however, further augmented I Ca,L producing synergistic effect comparable to that of IBMX. 38 Similar to human AM, dual PDE3+PDE4 inhibition in rabbit SANC worked in a synergistic manner and increased I Ca,L amplitude by ≈100%, whereas inhibition of PDE4 or PDE3 alone either had no effect or moderately increased I Ca,L by ≈60%, respectively ( Figure 6 ). In the mouse heart, PDE4B has been identified as a part of the L-type Ca 2+ channel complex and was the major PDE isoform modulating I Ca,L amplitude during β-AR stimulation. 39 In our study, PDE4B and PDE3A were colocalized beneath sarcolemma of SANC ( Figure 2B ), suggesting that these PDE subtypes could work together restraining Ca 2+ influx through L-type Ca 2+ channels in a synergistic manner.
Considering that PDE inhibition increases cAMP level, we examined contribution of I f current in the acceleration of spontaneous SANC firing by dual PDE3+PDE4 inhibition. As expected, suppression of I f current by either ivabradine or Cs + decreased spontaneous SANC beating rate, but acceleration of spontaneous firing by dual PDE3+PDE4 inhibition remained preserved regardless of I f inhibition ( Figure 5D ; Figures III and IV in the Data Supplement). Thus, regulation of spontaneous SANC firing by dual PDE3+PDE4 activation bypassed funny current. This result may be explained by specific location of I f channels to lipid rafts in rabbit SANC, 40 which might provide a spatial barrier between I f channels and increase in cAMP level produced by dual PDE3+PDE4 inhibition. This idea was supported by a recent study, which demonstrated that the positive chronotropic effect of cAMP-dependent agent glucagon was because of a cAMP-mediated activation of I f current that was not limited by PDE3 or PDE4 activation. Whereas synergism between PDE3 and PDE4 has been noted before in different cell types, 8, [16] [17] [18] [19] specific mechanisms that explain synergistic effect of dual PDE3+PDE4 inhibition remains enigma. This synergistic effect could be based on colocalization of PDE3 and PDE4 ( Figure 2 ) and specific interaction between these phosphodiesterases. Though both PDE3 and PDE4 can degrade cAMP, their affinities for cAMP are different; PDE3 degrades cAMP in the range of 10 to 100 nmol/L, 42 whereas PDE4 degrades cAMP in the range of 2 to 8 μmol/L. 43 Therefore, in the basal state when cAMP is relatively low, only PDE3 is, likely, active, whereas PDE4 remains dormant. It was shown that PDE4 could be activated by phosphorylation, 44 for example, PKA-dependent phosphorylation of PDE4 was associated with 2-to 6-fold increase in PDE4 activity. 45 Inhibition of PDE3 could be prerequisite for PDE4 activation, that is, PDE3 inhibition increases both local cAMP-and PKA-dependent phosphorylation, shifting cAMP level within the degradation range of PDE4 and concurrently activating PDE4 via PKA-dependent phosphorylation. Thus, cAMP level in the cell could be dynamically regulated by a negative feedback involving PKA-dependent stimulation of PDE4. In this case, modulation of spontaneous SANC firing by PDE3 and PDE4 could be self-adaptive with full functional effect achieved only when both PDE3 and PDE4 are concurrently inhibited. Furthermore, synchronized regulation/ suppression of several targets (L-type Ca 2+ channels, PLB, etc.) by dual PDE3+PDE4 activation in a synergistic manner could be energetically beneficial because minor changes in local cAMP levels at multiple locations could lead to substantial functional responses.
Clinical Implications of Concurrent PDE3+PDE4 Inhibition
Recently, dual PDE3+PDE4 inhibitors were accepted to treat patients with allergic rhinitis, asthma, and chronic obstructive pulmonary disease. In small clinical trials, dual PDE3/PDE4 inhibitor (RPL554: Verona Pharma) improved lung function without gastrointestinal side effects of classical PDE4 inhibitors. 46, 47 Synergy of combined PDE3+PDE4 inhibition, which markedly increases drug efficacy and is beneficial in patients with asthma and chronic obstructive pulmonary disease, 15 may also produce another type of side effects. Present report revealed that spontaneous beating rate of cardiac pacemaker cells was under control of dual PDE3+PDE4 activation which operated in a synergistic manner.
Though there is no information on PDE subtypes in the human sinoatrial node, PDE3 and PDE4 represent major PDE activities in human AM. 37 The resemblance between I Ca,L regulation by dual PDE3+PDE4 activation in human and rabbit AM 38 suggests that the same type of I Ca,L regulation might exist both in rabbit (present study) and human SANC. In this case, dual PDE3+PDE4 inhibition might increase spontaneous beating rate of the human heart leading to tachycardia, which could provoke atrial fibrillation. Finally, the resting heart rate in humans is associated with cardiovascular disease and death, and the risks for those increase gradually from the lowest to the highest resting heart rate values. 48 Our results suggest that changes in the human heart rate should be carefully monitored in any treatments that use dual PDE3+PDE4 inhibitors.
Study Limitations
In this report, we established that PDE3 and PDE4, working together, regulate/suppress basal spontaneous beating of cardiac pacemaker cells likely through the activation of PDE3A and PDE4B/D. We also found specific targets, that is, I Ca,L , PLB and possibly others (beyond scope of the present study), which were modulated by dual PDE3+PDE4 activation. Additional studies, however, are needed to verify our results in human SANC and elucidate not only mechanisms of PDE3 and PDE4 interactions but also interactions of specific PDE3/4 isoforms. Unfortunately, no pharmacological tools exist currently to determine exact functional contributions of specific PDE3 or PDE4 isoforms.
